All Bills - Us Congress 2025-2026 Regular Session
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1092
Introduced
3/24/25
Refer
3/24/25
A bill to require certain products to be labeled with 'Do Not Flush' labeling, and for other purposes.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1093
Introduced
3/24/25
Refer
3/24/25
Report Pass
3/27/25
A bill to amend the Small Business Act to enhance the Office of Rural Affairs, and for other purposes.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1094
Introduced
3/24/25
Refer
3/24/25
A bill to establish a contracting preference for public buildings that use innovative wood products in the construction of those buildings, and for other purposes.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1095
Introduced
3/24/25
Refer
3/24/25
Report Pass
4/3/25
A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1096
Introduced
3/24/25
Refer
3/24/25
Report Pass
4/3/25
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1097
Introduced
3/24/25
Refer
3/24/25
Report Pass
4/3/25
A bill to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1098
Introduced
3/24/25
Refer
3/24/25
A bill to amend the Omnibus Crime Control and Safe Streets Act of 1968 to enhance the Comprehensive Opioid Abuse Grant Program, and for other purposes.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1099
Introduced
3/25/25
Refer
3/25/25
A bill to amend title 28, United States Code, to limit the authority of district courts of the United States to provide injunctive relief, and for other purposes.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB110
Introduced
1/16/25
Refer
1/16/25
A bill to amend the Federal Credit Union Act to exclude extensions of credit made to veterans from the definition of a member business loan.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1100
Introduced
3/25/25
Refer
3/25/25
A bill to amend the Food and Nutrition Act to modify the definition of food under the supplemental nutrition assistance program, and for other purposes.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1101
Introduced
3/25/25
Refer
3/25/25
A bill to authorize the use of Federal Bureau of Investigation criminal history record information for administration of certain licenses.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1102
Introduced
3/25/25
Refer
3/25/25
A bill to incentivize States and localities to improve access to justice, and for other purposes.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1103
Introduced
3/25/25
Refer
3/25/25
A bill to require a pilot program on the use of big data analytics to identify vessels evading sanctions and export controls and to require a report on the availability in the United States of emerging and foundational technologies subject to export controls.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1104
Introduced
3/25/25
Refer
3/25/25
A bill to amend section 495 of the Public Health Service Act to require inspections of foreign laboratories conducting biomedical and behavioral research to ensure compliance with applicable animal welfare requirements, and for other purposes.
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1105
Introduced
3/25/25
Refer
3/25/25
<p><b>No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act or the No UPCODE Act</b></p> <p>This bill modifies certain factors that are used to determine Medicare Advantage (MA) payments, particularly relating to health status and related data. </p> <p>Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to use two years of diagnostic data in its risk adjustment methodology for MA payments. It also prohibits the CMS from using diagnoses that are collected from chart reviews or health risk assessments when adjusting payments based on health status. The CMS must also take into account any differences in coding patterns between MA and traditional Medicare when determining MA payment adjustments.</p>